Pharmaids Pharmaceuticals Ltd.

View in App
38.25 -1.75 ▼-4.4%

06 December 2023, 04:01:00 PM
Volume: 11,174

Company Profile

View details >>
Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pharmaids.com
Market Cap 83.62 Cr.
Enterprise Value(EV) 82.18 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -4.05 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.60 Trailing Twelve Months Ending 2023-09
Book Value / Share 9.38 Trailing Twelve Months Ending 2023-09
Price to Book Value 4.15 Calculated using Price: 38.92
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 2.15 Cr. 21,486,234 Shares
FaceValue 10
About Pharmaids Pharmaceuticals Ltd.
The Company is engaged in the business of Trading and Manufacturing of Generics, Bulk Drugs and Intermediaries, etc.

Pharmaids Pharmaceuticals Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Pharmaids Pharmaceuticals Ltd. Performance

View details >>
1 Day
-4.38%
1 Week
-3.29%
1 Month
-15.00%
3 Month
-1.26%
6 Month
+27.50%
1 Year
+101.85%
2 Year
+160.20%
5 Year
+712.10%
10 Year
+1018.42%

Pharmaids Pharmaceuticals Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -3.71 -26.21 7.99 -31.24 -3.76 0.40 1.10 1.69 -49.34
Return on Capital Employed (%) -4.99 -21.19 7.61 -29.73 -3.02 -4.45 1.04 1.66 -63.94
Return on Assets (%) -2.42 -16.50 5.08 -23.27 -3.56 0.40 1.11 1.49 -46.35

Pharmaids Pharmaceuticals Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2 1 1 1 8 8 9 9 22 21
Non Curr. Liab. 0 0 0 0 0 0 0 0 -3 -3
Curr. Liab. 1 1 1 0 0 0 1 2 2 0
Minority Int.
Equity & Liab. 3 2 2 1 9 8 9 11 22 17
Non Curr. Assets 1 1 0 1 4 8 8 8 4 16
Curr. Assets 2 2 2 1 4 0 1 3 17 1
Misc. Exp. not W/O 0
Total Assets 3 2 2 1 9 8 9 11 22 17

Pharmaids Pharmaceuticals Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 2 2 1 0 1 9 4
Other Income 0 0 0 0 0 0 0 0
Total Income 2 2 1 0 1 9 4 0
Total Expenditure -2 -2 -2 -1 -1 0 -8 -4 -10 -12
PBIDT 0 0 0 0 0 0 0 0 -10 -12
Interest 0 0
Depreciation 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 0 2 3
Exceptional Items 1
PAT 0 0 0 0 0 0 0 0 -8 -9
Adjusted EPS 0 -1 0 -1 0 0 0 0 -4 -4

Pharmaids Pharmaceuticals Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 0 -1 0 0 -4
Cash Fr. Inv. 0 0 0 0 1 0 0 -5
Cash Fr. Finan. 0 0 0 0 0 0 21
Net Change 0 0 0 0 0 0 0 0 0 12
Cash & Cash Eqvt 0 0 0 1 0 0 0 0 0 13

Pharmaids Pharmaceuticals Ltd. Shareholding Pattern

View details >>
9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 65.65 55.56 35.44 20.70 20.97 16.52 9.95 9.94 9.70
Public 34.35 44.44 64.56 79.30 79.03 83.48 90.05 90.06 90.30
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Pharmaids Pharmaceuticals Ltd. Announcements

View details >>
Tue, 28 Nov 2023
Disclosure Under Regulation 7(2)(B) Of SEBI (Prohibition Of Insider Trading) Regulations 2015
Pursuant to Regulation 7(2)(b) of SEBI(Prohibition of Insider Trading) Regulations 2015 Company has received "Form B" from Mr. Sadhanala Venkata Rao Promoter of the Company in respect of sale of equity shares of the company.
Fri, 24 Nov 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Sadhanala Venkata Rao
Sun, 12 Nov 2023
Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of SEBI(LODR) Regulations 2015 enclosing herewith copies of newpaper publication providing extract of un-audited financial results in English and Kannada Newspaper for the quarter and half year ended September 30 2023.

Pharmaids Pharmaceuticals Ltd. Technical Scans

View details >>
Wed, 06 Dec 2023
Opening at Low Opening at Low
Making Higher Highs for 3 days Making Higher Highs for 3 days
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Decrease in 1 Month High Decrease in 1 Month
High Increase in 6 Months High Increase in 6 Months

Pharmaids Pharmaceuticals Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 297,505.54 1,240.35 +0.1%
Divi's Laboratories Ltd. 99,132.60 3,734.45 -0.2%
Cipla Ltd. 97,689.40 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. 95,542.33 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. 79,632.26 5,543.10 -0.7%
Mankind Pharma Ltd. 78,289.00 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. 70,428.80 2,080.95 -0.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.80 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 74.44 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-09 28.29 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.77 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.17 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 61.07 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.80 2,080.95 -0.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.97 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-09 7.82 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-09 3.94 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.75 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.25 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 9.29 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.50 2,080.95 -0.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 0.02 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,080.95 -0.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.95 -0.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 12.85 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,080.95 -0.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,080.95 -0.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,240.35 +0.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,734.45 -0.2%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,205.20 -1.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,730.35 -0.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,543.10 -0.7%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,949.80 +0.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,080.95 -0.9%

Pharmaids Pharmaceuticals Ltd. FAQ's

What is Pharmaids Pharma share price?
Can I buy Pharmaids Pharma shares now?
What is the Market Cap of Pharmaids Pharma?
What are the key metrics to analyse Pharmaids Pharma?
What is the 52 Week High and Low of Pharmaids Pharma?
What is the trend of Pharmaids Pharma share price?